glp-1 drugs fda approved medicare part d coverage 2025 Navigating Changes What to Know About the
Description
Concerns about thyroid cancer risk and the potential for sarcopenia or bone fragility in older patients further underscore the need for long-term surveillance (Nunn et al., 2024)
2016a;39:157986
2025 Mar;13(3):e6
The researchers suggest that reductions in inflammation and protein production, and improved insulin signaling, may be involved
